Less lung tissue removal needed for early-stage cancer, study finds

byWeill Cornell Medical CollegeCredit: AI-generated imageSurgery that removes only a portion of one of the five lobes that comprise a lung is as effective as the traditional surgery that removes

Updated on: January 23,2024

Less lung tissue removal needed for early-stage cancer, study finds

byWeill Cornell Medical CollegeCredit: AI-generated imageSurgery that removes only a portion of one of the five lobes that comprise a lung is as effective as the traditional surgery that removes

Updated on:January 23,2024

Drug-like molecules show early success in targeting breast cancer brain metastases

byDrexel UniversityComputational pipeline and predicted drug-like properties for the discovery of AD-2441 and its analogs. Credit:Frontiers in Pharmacology(2024). DOI: 10.3389/fphar.

Updated on: August 01,2024

Drug-like molecules show early success in targeting breast cancer brain metastases

byDrexel UniversityComputational pipeline and predicted drug-like properties for the discovery of AD-2441 and its analogs. Credit:Frontiers in Pharmacology(2024). DOI: 10.3389/fphar.

Updated on:August 01,2024

Researchers discover pathway critical for lymphoma development

by H. Lee Moffitt Cancer Center & Research InstituteActivation of the polyamine-hypusine circuit is a hallmark of human cancer and of MYC-driven lymphoma. A, Copy number alterations (CNA) of

Updated on: February 20,2024

Researchers discover pathway critical for lymphoma development

by H. Lee Moffitt Cancer Center & Research InstituteActivation of the polyamine-hypusine circuit is a hallmark of human cancer and of MYC-driven lymphoma. A, Copy number alterations (CNA) of

Updated on:February 20,2024

Access to genomic medicine illustrates precision medicine's delicate future

byOsaka UniversityTest Availability of Multigene Panel Tests in Japan and SwitzerlandCC BY, Nakasato K, Manz C and Kato K (2024) Access, autonomy, and affordability: ethical and human rights iss

Updated on: April 28,2024

Access to genomic medicine illustrates precision medicine's delicate future

byOsaka UniversityTest Availability of Multigene Panel Tests in Japan and SwitzerlandCC BY, Nakasato K, Manz C and Kato K (2024) Access, autonomy, and affordability: ethical and human rights iss

Updated on:April 28,2024

ASCO: undertreatment seen for women with head and neck cancer

(HealthDay)—Females with head and neck cancer (HNC) are less likely to receive intensive chemotherapy and radiation, and have an increased relative risk for death from HNC versus other causes, accordi

Updated on: March 30,2024

ASCO: undertreatment seen for women with head and neck cancer

(HealthDay)—Females with head and neck cancer (HNC) are less likely to receive intensive chemotherapy and radiation, and have an increased relative risk for death from HNC versus other causes, accordi

Updated on:March 30,2024

New study unveils epigenetic 'traffic lights' controlling stop and go for gene activity

by Institute of Cancer ResearchAcute depletion of SET1/COMPASS core subunits reveals rapid turnover of H3K4me3.a, Schematic of the degron systems for the targeted degradation of DPY30 and R

Updated on: February 23,2024

New study unveils epigenetic 'traffic lights' controlling stop and go for gene activity

by Institute of Cancer ResearchAcute depletion of SET1/COMPASS core subunits reveals rapid turnover of H3K4me3.a, Schematic of the degron systems for the targeted degradation of DPY30 and R

Updated on:February 23,2024

Researchers design gene therapy that can effectively target glioblastoma

by Brigham and Women's HospitalGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Glioblastoma (GBM), an aggressive brain cancer, is notoriously resistant to treatment, with recurr

Updated on: June 06,2024

Researchers design gene therapy that can effectively target glioblastoma

by Brigham and Women's HospitalGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Glioblastoma (GBM), an aggressive brain cancer, is notoriously resistant to treatment, with recurr

Updated on:June 06,2024

Team studies association between tumor mutations and meningioma recurrence in Grade I/II disease

by Impact JournalsAdjusted progression-free survival hazard ratios for genes examined. Credit: 2022 Dullea et al.A new research paper titled "Association between tumor mutations and meningioma re

Updated on: February 03,2024

Team studies association between tumor mutations and meningioma recurrence in Grade I/II disease

by Impact JournalsAdjusted progression-free survival hazard ratios for genes examined. Credit: 2022 Dullea et al.A new research paper titled "Association between tumor mutations and meningioma re

Updated on:February 03,2024

Researchers uncover racial and ethnic disparities in a widely used precision oncology data registry

by Katie Marquedant,Massachusetts General HospitalSample size estimation to detect differences in mutational proportions between white and racial/ethnic minority patients at varying power increm

Updated on: February 18,2024

Researchers uncover racial and ethnic disparities in a widely used precision oncology data registry

by Katie Marquedant,Massachusetts General HospitalSample size estimation to detect differences in mutational proportions between white and racial/ethnic minority patients at varying power increm

Updated on:February 18,2024

Researchers identify promising new target for drug-resistant breast and ovarian cancers

by Lisa Marshall, University of Colorado at BoulderGraphical abstract. Credit:Molecular Cell(2023). DOI: 10.1016/j.molcel.2023.03.017CU Boulder researchers have discovered a protein's

Updated on: February 01,2024

Researchers identify promising new target for drug-resistant breast and ovarian cancers

by Lisa Marshall, University of Colorado at BoulderGraphical abstract. Credit:Molecular Cell(2023). DOI: 10.1016/j.molcel.2023.03.017CU Boulder researchers have discovered a protein's

Updated on:February 01,2024

Researchers identified a protein associated with breast cancer

by Cathy Frisinger,UT Southwestern Medical CenterDr. Yingfei Wang says depleting the protein ZMYND8 blocks the growth of new blood vessels in breast cancer. Credit: UT Southwestern Medical Cente

Updated on: June 19,2024

Researchers identified a protein associated with breast cancer

by Cathy Frisinger,UT Southwestern Medical CenterDr. Yingfei Wang says depleting the protein ZMYND8 blocks the growth of new blood vessels in breast cancer. Credit: UT Southwestern Medical Cente

Updated on:June 19,2024

Tumor macrophage marker offers unique target for treatment

by National Institutes of HealthA nanoparticle attached to CRV (CRV-NP) specifically homed to macrophages in breast tumors in mice (yellow arrow) and did not home to spleen, lung or heart. Nanopa

Updated on: April 09,2024

Tumor macrophage marker offers unique target for treatment

by National Institutes of HealthA nanoparticle attached to CRV (CRV-NP) specifically homed to macrophages in breast tumors in mice (yellow arrow) and did not home to spleen, lung or heart. Nanopa

Updated on:April 09,2024